These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6859841)

  • 21. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of trehalose fermentation and L-glutamic acid decarboxylation for identification of biochemically aberrant Providencia stuartii strains.
    Fischer R; Penner JL; Zurinaga G; Riddle C; Sämisch W; Brenner DJ
    J Clin Microbiol; 1989 Sep; 27(9):1969-72. PubMed ID: 2570791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance in Providencia stuartii isolated in hospitals.
    McHale PJ; Keane CT; Dougan G
    J Clin Microbiol; 1981 Jun; 13(6):1099-104. PubMed ID: 7251830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O serotyping of Providencia stuartii isolates collected from twelve hospitals.
    Penner JL; Hinton NA; Duncan IB; Hennessy JN; Whiteley GR
    J Clin Microbiol; 1979 Jan; 9(1):11-4. PubMed ID: 429535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimal dosage of semisynthetic penicillins. II. Microbiological research].
    Schioppacassi G; Curcio L; Perrotta P
    G Ital Chemioter; 1975; 22(1-2):95-8. PubMed ID: 828598
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.
    Bodey GP; Stewart D
    Appl Microbiol; 1971 Apr; 21(4):710-7. PubMed ID: 4930281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of Proteus species and Pseudomonas aeruginosa to penicillins and cephalosporins.
    Adler JL; Burke JP; Wilcox C; Finland M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():63-7. PubMed ID: 5000270
    [No Abstract]   [Full Text] [Related]  

  • 28. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
    Baltimore RS; Klein JO; Wilcox C; Finland M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of the fatty acid composition of Providencia alcalifaciens and Providencia stuartii lipids].
    Vasiurenko ZP; Cherniavskaia EN; Open'ko LV
    Mikrobiologiia; 1982; 51(1):54-9. PubMed ID: 7070309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus.
    Hyams PJ; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1974 Jun; 5(6):571-7. PubMed ID: 15825407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.
    O'Hara CM; Brenner FW; Miller JM
    Clin Microbiol Rev; 2000 Oct; 13(4):534-46. PubMed ID: 11023955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kanamycin resistance in Providencia stuartii.
    McHale P; English L; Speekenbrink A; Keane C
    J Antimicrob Chemother; 1978 May; 4(3):273-8. PubMed ID: 670120
    [No Abstract]   [Full Text] [Related]  

  • 36. Sensitivity of Proteus and Providencia to eight antibiotics and sulfathiazole; tested by the tablet method.
    PERCH B
    Acta Pathol Microbiol Scand; 1954; 35(3):278-86. PubMed ID: 13197048
    [No Abstract]   [Full Text] [Related]  

  • 37. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activity of temocillin.
    Gobernado M; Canton E
    Drugs; 1985; 29 Suppl 5():24-31. PubMed ID: 4029029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000).
    Kim BN; Kim NJ; Kim MN; Kim YS; Woo JH; Ryu J
    Scand J Infect Dis; 2003; 35(2):98-103. PubMed ID: 12693558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of endemic Providencia stuartii isolates from patients with urinary devices.
    Hollick GE; Nolte FS; Calnan BJ; Penner JL; Barton LJ; Spellacy A
    Eur J Clin Microbiol; 1984 Dec; 3(6):521-5. PubMed ID: 6526019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.